Open access
Sep 2026
Yinqi Tiaozhi Decoction ameliorates hepatic steatosis in metabolic dysfunction-associated fatty liver disease by regulating the miR-122-5p/FOXO3 axis to modulate lipid metabolism and oxidative stress
YQTZD mitigates hepatic steatosis, oxidative damage, and inflammation in MAFLD, mechanistically linked to miR-122-5p downregulation-mediated FOXO3 upregulation and provides a mechanistic foundation for its future integration into clinical management of MAFLD.
Li-Ping Zhou, Yan-Feng Huang, Feng Tian et al.
· Eurasian Journal of Medicine... · 0 citations